Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Prieto-Merino

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Journal of Intensive Care|February 24, 2015
Applying results from clinical trials: tranexamic acid in trauma patientsIan Roberts, David Prieto-Merino
Lancet (London, England)|December 3, 2014
Blood pressure lowering and cardiovascular riskIan Roberts, David Prieto-Merino
European Journal of Preventive Cardiology|July 18, 2012
The science of risk modelsDavid Prieto-Merino, Stuart J Pocock
Plos One|July 29, 2022
A systematic review of statistical methodology used to evaluate progression of chronic kidney disease using electronic healthcare recordsFaye Cleary, David Prieto-Merino, Dorothea Nitsch
Critical Care (London, England)|December 16, 2014
Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trialIan Roberts, David Prieto-Merino, Daniela Manno
SSM - Population Health|January 20, 2018
Differences in stroke and ischemic heart disease mortality by occupation and industry among Japanese working-aged menKoji Wada, Hisashi Eguchi, David Prieto-Merino
British Journal of Clinical Pharmacology|October 24, 2018
Identifying signals of potentially harmful medications in pregnancy: use of the double false discovery rate method to adjust for multiple testingAlana Cavadino, David Prieto-Merino, Joan K Morris
Pharmacoepidemiology and Drug Safety|January 8, 2020
Bayesian hierarchical methods in the detection of potentially teratogenic first-trimester medicationsAlana Cavadino, David Prieto-Merino, Joan K Morris
Pharmaceutical Statistics|December 6, 2011
Why a Bayesian approach to safety analysis in pharmacovigilance is importantDavid Prieto-Merino, George Quartey, Jixian Wang, et al.
Plos One|May 13, 2022
Hidden heterogeneity: Uncovering patterns of adherence in microbicide trials for HIV preventionLori Miller, David Prieto Merino, Kathy Baisley, et al.
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Journal of Intensive Care|February 24, 2015
Applying results from clinical trials: tranexamic acid in trauma patientsIan Roberts, David Prieto-Merino
Lancet (London, England)|December 3, 2014
Blood pressure lowering and cardiovascular riskIan Roberts, David Prieto-Merino
European Journal of Preventive Cardiology|July 18, 2012
The science of risk modelsDavid Prieto-Merino, Stuart J Pocock
Plos One|July 29, 2022
A systematic review of statistical methodology used to evaluate progression of chronic kidney disease using electronic healthcare recordsFaye Cleary, David Prieto-Merino, Dorothea Nitsch
Critical Care (London, England)|December 16, 2014
Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trialIan Roberts, David Prieto-Merino, Daniela Manno
SSM - Population Health|January 20, 2018
Differences in stroke and ischemic heart disease mortality by occupation and industry among Japanese working-aged menKoji Wada, Hisashi Eguchi, David Prieto-Merino
British Journal of Clinical Pharmacology|October 24, 2018
Identifying signals of potentially harmful medications in pregnancy: use of the double false discovery rate method to adjust for multiple testingAlana Cavadino, David Prieto-Merino, Joan K Morris
Pharmacoepidemiology and Drug Safety|January 8, 2020
Bayesian hierarchical methods in the detection of potentially teratogenic first-trimester medicationsAlana Cavadino, David Prieto-Merino, Joan K Morris
Pharmaceutical Statistics|December 6, 2011
Why a Bayesian approach to safety analysis in pharmacovigilance is importantDavid Prieto-Merino, George Quartey, Jixian Wang, et al.
Plos One|May 13, 2022
Hidden heterogeneity: Uncovering patterns of adherence in microbicide trials for HIV preventionLori Miller, David Prieto Merino, Kathy Baisley, et al.
Pageof 12